Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore
60-Word AI Digest
Emcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore. Revenue grew 24.3%, while EBITDA rose 30.9%, supported by strong international business growth.
Key Takeaways
- Emcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore.
- Revenue grew 24.3%, while EBITDA rose 30.9%, supported by strong international business growth.
- Full details and original dispatch available below.
Emcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore. Revenue grew 24.3%, while EBITDA rose 30.9%, supported by strong international business growth.
Original Publisher Attribution
This summary was curated from Economic Times.